Also, we found that the AR expression depends on PR and ER expression levels in the luminal B HER2-negative subtype: the AR mRNA level was increased in BC tissues of patients with a high expression of these receptors compared with BC tissues of patients with a low expression of PR and ER. This evidence concerns the gene ERBB2 and breast cancer.